Eli Lilly agreed to acquire Bothell, Wash.-based Curevo Vaccine for up to $1.5 billion in cash. The deal centers on a next-generation shingles vaccine that reduced side effects by more than half in a Phase 2 study. Read More
โก
Key Insights
10 editorial insights.
AiFeed24 Teamยทโฑ 1 min readยทStartups
Deep Analysis
Multi-Source Intelligence
Found this useful? Share it!
Related Stories

๐Startups
AI Revolutionizes Business Continuity: From Resilience to Robust Survivability
about 2 hours ago

๐Startups
XCENA secures $135M to advance its computational memory technology
about 4 hours ago

๐Startups
MIT's MeMo lets teams swap in a better LLM without retraining โ and performance jumps 26%
about 7 hours ago

๐Startups
Blue Originโs New Glenn rocket explodes on launchpad during test
about 6 hours ago
